Suppr超能文献

相似文献

1
Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
Genes Dev. 2004 Jul 1;18(13):1592-605. doi: 10.1101/gad.1200204.
3
Role of histone H3 lysine 27 methylation in Polycomb-group silencing.
Science. 2002 Nov 1;298(5595):1039-43. doi: 10.1126/science.1076997. Epub 2002 Sep 26.
4
Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.
EMBO J. 2004 Oct 13;23(20):4061-71. doi: 10.1038/sj.emboj.7600402. Epub 2004 Sep 23.
6
The polycomb group protein SUZ12 regulates histone H3 lysine 9 methylation and HP1 alpha distribution.
Chromosome Res. 2007;15(3):299-314. doi: 10.1007/s10577-007-1126-1. Epub 2007 May 10.
7
A model for transmission of the H3K27me3 epigenetic mark.
Nat Cell Biol. 2008 Nov;10(11):1291-300. doi: 10.1038/ncb1787. Epub 2008 Oct 19.
8
Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.
Mol Cell. 2004 Apr 23;14(2):183-93. doi: 10.1016/s1097-2765(04)00185-6.
9
Developmental regulation of Suz 12 localization.
Chromosoma. 2005 Aug;114(3):183-92. doi: 10.1007/s00412-005-0008-6. Epub 2005 Jun 29.
10
The polycomb repressive complex 2 is a potential target of SUMO modifications.
PLoS One. 2008 Jul 16;3(7):e2704. doi: 10.1371/journal.pone.0002704.

引用本文的文献

4
Epigenetics in Skin Homeostasis and Ageing.
Epigenomes. 2025 Jan 9;9(1):3. doi: 10.3390/epigenomes9010003.
6
p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer.
bioRxiv. 2024 May 23:2024.03.29.587346. doi: 10.1101/2024.03.29.587346.
7
The potential of EZH2 expression to facilitate treatment choice in stage II colorectal adenocarcinoma.
Histol Histopathol. 2024 Oct;39(10):1371-1379. doi: 10.14670/HH-18-732. Epub 2024 Mar 8.
8
An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer.
iScience. 2023 Jun 14;26(7):107115. doi: 10.1016/j.isci.2023.107115. eCollection 2023 Jul 21.
9
Polycomb Group Protein CBX7 Represses Cardiomyocyte Proliferation Through Modulation of the TARDBP/RBM38 Axis.
Circulation. 2023 Jun 13;147(24):1823-1842. doi: 10.1161/CIRCULATIONAHA.122.061131. Epub 2023 May 9.
10
TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma.
Theranostics. 2022 Oct 3;12(16):7032-7050. doi: 10.7150/thno.74197. eCollection 2022.

本文引用的文献

1
Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.
Mol Cell. 2004 Apr 23;14(2):183-93. doi: 10.1016/s1097-2765(04)00185-6.
2
Polycomb silencing blocks transcription initiation.
Mol Cell. 2004 Mar 26;13(6):887-93. doi: 10.1016/s1097-2765(04)00128-5.
3
High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays.
Methods Enzymol. 2004;376:315-34. doi: 10.1016/S0076-6879(03)76021-2.
4
Polycomb group proteins in cell cycle progression and cancer.
Cell Cycle. 2004 Apr;3(4):396-400. Epub 2004 Apr 1.
6
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11606-11. doi: 10.1073/pnas.1933744100. Epub 2003 Sep 19.
7
Identification and characterization of polyhomeotic PREs and TREs.
Dev Biol. 2003 Sep 15;261(2):426-42. doi: 10.1016/s0012-1606(03)00314-2.
8
E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9.
J Biol Chem. 2003 Oct 24;278(43):42466-76. doi: 10.1074/jbc.M307733200. Epub 2003 Aug 8.
9
Assembly of Polycomb complexes and silencing mechanisms.
Genetica. 2003 Mar;117(2-3):191-7. doi: 10.1023/a:1022992011833.
10
A 1-megadalton ESC/E(Z) complex from Drosophila that contains polycomblike and RPD3.
Mol Cell Biol. 2003 May;23(9):3352-62. doi: 10.1128/MCB.23.9.3352-3362.2003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验